ArticleCancer management and research2020

Programmed Death-1 Receptor (PD-1) as a Potential Prognosis Biomarker for Ovarian Cancer Patients.

Anna Pawłowska et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.